Amicus Therapeutics, Inc. 0HF9.L
0HF9.L
Amicus Therapeutics, Inc. 0HB0.L
Agios Pharmaceuticals, Inc. 0L35.L
Sarepta Therapeutics, Inc. 0KCS.L
OPKO Health, Inc. 0JBU.L
Intellia Therapeutics, Inc. 0EE0.L
uniQure N.V. 0H7R.L
Abeona Therapeutics Inc. 0LB2.L
Supernus Pharmaceuticals, Inc. 0IV3.L
Geron Corporation 0Y5E.L
Perrigo Company plc
Amicus Therapeutics, Inc. 0HB0.L
Agios Pharmaceuticals, Inc. 0L35.L
Sarepta Therapeutics, Inc. 0KCS.L
OPKO Health, Inc. 0JBU.L
Intellia Therapeutics, Inc. 0EE0.L
uniQure N.V. 0H7R.L
Abeona Therapeutics Inc. 0LB2.L
Supernus Pharmaceuticals, Inc. 0IV3.L
Geron Corporation 0Y5E.L
Perrigo Company plc
Performance
| Periode | 0HF9.L | 0HB0.L | 0L35.L | 0KCS.L | 0JBU.L | 0EE0.L | 0H7R.L | 0LB2.L | 0IV3.L | 0Y5E.L |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 21.04 % | 47.27 % | -61.66 % | 2.15 % | 78.06 % | 364.84 % | 3.86 % | 66.18 % | -10.53 % | -12.81 % |
| YTD | -5.84 % | 30.59 % | -81.42 % | -2.65 % | 20.08 % | 264.36 % | -4.75 % | 46.51 % | -65.00 % | -16.74 % |
| 1Y | -23.55 % | -5.51 % | -82.03 % | -1.99 % | -11.14 % | 867.01 % | -17.32 % | 54.59 % | -69.61 % | -14.52 % |
| 3Y | -15.86 % | 51.80 % | -79.13 % | -22.85 % | -72.58 % | 250.66 % | 28.86 % | 53.39 % | -46.62 % | -34.39 % |
| 5Y | -7.13 % | 27.96 % | -69.75 % | -52.29 % | -84.90 % | 54.80 % | -86.21 % | 143.19 % | -26.56 % | -34.39 % |
| 10Y | -7.13 % | -45.85 % | -69.75 % | -52.29 % | -84.90 % | 241.62 % | -98.57 % | 28.37 % | -37.10 % | -34.39 % |
| From the beginning | -7.13 % | -45.85 % | -69.75 % | -52.29 % | -84.90 % | 241.62 % | -98.57 % | 28.37 % | -37.10 % | -34.39 % |